18 June 2021 1 Min Read
Thiel-backed psychedelics firm Atai valued at $3.2bn in US debut
Shares of Atai Life Sciences, backed by billionaire investor Peter Thiel, jumped 40% in their US stock market debut
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In